uploads///clx anr

How Do Analysts Rate Clorox and Its Peers?

Gabriel Kane - Author
By

Dec. 4 2020, Updated 10:43 a.m. ET

Analyst coverage

Of the 17 analysts covering Clorox (CLX), two analysts have rated the stock as a “buy” as of November 2. The stock is rated as a “hold” by 65.0% of analysts and a “sell” by 23.0% of analysts. Clorox manufactures and markets consumer and professional products. The company is trying to boost its sales and enhance shareholder returns through its Strategy 2020 program. However, currency headwinds, difficult market conditions, and intense competition are impacting the company’s performance.

Clorox constitutes 2.7% of the Guggenheim S&P 500 Equal Weight Consumer Staples ETF (RHS).

Article continues below advertisement

12-month price target

As on November 2, the 12-month price target for Clorox Company was $127.38, which reflects a return potential of 10.1%. Argus Research has the highest price target for Clorox Company at $148.0 per share and has rated the stock as a “buy.” B. Riley & Co. has set the lowest price target for Clorox Company at $109.0 per share compared to other analysts.

Comparison with peers

Out of 27 analysts covering Procter & Gamble’s (PG) stock, 55.0% rated the stock as a “buy,” 41.0% rated it as a “hold,” and 4.0% rated it as a “sell.” B. Riley & Co. has set the highest price target for PG at $106.0 per share, and RBC Capital Markets has set the lowest price target for the stock at $76.0 per share.

Out of 25 analysts covering Colgate-Palmolive’s (CL) stock, 20.0% rated the stock as “buy” and 80.0% rated it as “hold.” Atlantic Equities has the highest price target for Colgate-Palmolive at $85.0 per share, and SunTrust Robinson Humphrey has set the lowest price target for Colgate-Palmolive at $70.0 per share out of all the analysts.

For Kimberly-Clark (KMB), 19.0% of 16 analysts rated the stock a “buy,” 69.0% rated it as a “hold,” and 12.0% rated it as a “sell.” Goldman Sachs has set the highest price target for Kimberly-Clark at $145.0 per share, and Bernstein has set the lowest price target for the stock at $117.0 per share out of all the analysts.

We’ll discuss the company’s valuation in the concluding part of this series.

Advertisement

Latest Colgate-Palmolive Co News and Updates

    Market Realist Logo

    © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.